Literature DB >> 23040260

Senior adult oncology: three cases of advanced cancer in patients of advanced age.

Gloria J Morris1, Kristine Swartz, Andrew E Chapman, Stuart M Lichtman, Jason S Levitz, Farhad Ravandi, Kathryn R Chan.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23040260      PMCID： PMC4105700          DOI： 10.1053/j.seminoncol.2012.08.013

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  26 in total

Review 1.  Evaluating the older patient with cancer: understanding frailty and the geriatric assessment.

Authors:  Sumanta Kumar Pal; Vani Katheria; Arti Hurria
Journal:  CA Cancer J Clin       Date:  2010-02-19       Impact factor: 508.702

2.  Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer.

Authors:  Richard M Goldberg; Isabelle Tabah-Fisch; Harry Bleiberg; Aimery de Gramont; Christophe Tournigand; Thierry Andre; Mace L Rothenberg; Erin Green; Daniel J Sargent
Journal:  J Clin Oncol       Date:  2006-09-01       Impact factor: 44.544

3.  Postmastectomy radiation and survival in older women with breast cancer.

Authors:  Benjamin D Smith; Bruce G Haffty; Arti Hurria; Deron H Galusha; Cary P Gross
Journal:  J Clin Oncol       Date:  2006-10-20       Impact factor: 44.544

4.  Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.

Authors:  Stephen E Jones; Michael A Savin; Frankie Ann Holmes; Joyce A O'Shaughnessy; Joanne L Blum; Svetislava Vukelja; Kristi J McIntyre; John E Pippen; James H Bordelon; Robert Kirby; John Sandbach; William J Hyman; Pankaj Khandelwal; Angel G Negron; Donald A Richards; Stephen P Anthony; Robert G Mennel; Kristi A Boehm; Walter G Meyer; Lina Asmar
Journal:  J Clin Oncol       Date:  2006-12-01       Impact factor: 44.544

Review 5.  Understanding and treating triple-negative breast cancer.

Authors:  Carey Anders; Lisa A Carey
Journal:  Oncology (Williston Park)       Date:  2008-10       Impact factor: 2.990

6.  Impact of age and comorbidity on colorectal cancer screening among older veterans.

Authors:  Louise C Walter; Karla Lindquist; Sean Nugent; Tammy Schult; Sei J Lee; Michele A Casadei; Melissa R Partin
Journal:  Ann Intern Med       Date:  2009-04-07       Impact factor: 25.391

7.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

8.  Adjuvant chemotherapy in older women with early-stage breast cancer.

Authors:  Hyman B Muss; Donald A Berry; Constance T Cirrincione; Maria Theodoulou; Ann M Mauer; Alice B Kornblith; Ann H Partridge; Lynn G Dressler; Harvey J Cohen; Heather P Becker; Patricia A Kartcheske; Judith D Wheeler; Edith A Perez; Antonio C Wolff; Julie R Gralow; Harold J Burstein; Ahmad A Mahmood; Gustav Magrinat; Gutav Magrinat; Barbara A Parker; Ronald D Hart; Debjani Grenier; Larry Norton; Clifford A Hudis; Eric P Winer
Journal:  N Engl J Med       Date:  2009-05-14       Impact factor: 91.245

9.  Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.

Authors:  Frank A Scappaticci; Jamey R Skillings; Scott N Holden; Hans-Peter Gerber; Kathy Miller; Fairooz Kabbinavar; Emily Bergsland; James Ngai; Eric Holmgren; Jiuzhou Wang; Herbert Hurwitz
Journal:  J Natl Cancer Inst       Date:  2007-08-08       Impact factor: 13.506

Review 10.  Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology.

Authors:  Hans Wildiers; Ian Kunkler; Laura Biganzoli; Jacques Fracheboud; George Vlastos; Chantal Bernard-Marty; Arti Hurria; Martine Extermann; Véronique Girre; Etienne Brain; Riccardo A Audisio; Harry Bartelink; Mary Barton; Sharon H Giordano; Hyman Muss; Matti Aapro
Journal:  Lancet Oncol       Date:  2007-12       Impact factor: 41.316
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.